Calibration of immunohistochemistry for assessment of HER2 in breast cancer: results of the French Multicentre GEFPICS* Study

Histopathology - Tập 42 Số 4 - Trang 337-347 - 2003
Anne Vincent‐Salomon1, Gaétan MacGrogan, Jérôme Couturier, Laurent Arnould, Yves Denoux, Maryse Fiche, J Jacquemier, M.C. Mathieu, Frédérique Penault-Llorca, C Rigaud, Pascal Roger, Isabelle Treilleux, M O Vilain, Simone Mathoulin‐Pélissier, V Le Doussal
1Institut Curie, Paris, France. [email protected]

Tóm tắt

Aims:  HER2 protein is over‐expressed in 15–30% of breast carcinomas. Immunohistochemistry (IHC) is a common and inexpensive method able to specifically detect HER2 protein. However, lack of standardization of IHC has been considered responsible for discrepancies in HER2 status assessment performed by IHC and fluorescence in‐situ hybridization (FISH). This prompted us to perform a multicentric IHC calibration test to achieve a maximum accuracy of HER2‐IHC compared with HER2‐FISH taken as the reference method.Methods and results:  Twelve French laboratories participated in this study, including 119 cases of invasive breast carcinomas for which both fixed and frozen tissues were available. HER2 expression was determined in fixed tissues by individual in‐house IHC techniques, using either CB11 (Novocastra, Newcastle, UK) or A0485 (Dako, Glostrup, Denmark) anti‐HER2 antibodies. Two cut‐off values were used: 10% and 60% of immunostained cells. In 116 of the 119 cases, HER2 gene status could also be determined by FISH on frozen sections, performed in a single laboratory. Results were centralized and compared. When suboptimal concordance between IHC and FISH was observed, IHC was calibrated and a second run was performed. The specificity, sensitivity and accuracy of IHC compared with FISH were noted before and after calibration. Forty‐four out of 116 (38%) tumours showed HER2 gene amplification. Accuracy of IHC was complete in the first run for 6/12 laboratories. Calibration, necessary for the six others, relied mainly on the combination of a heat‐induced epitope retrieval step with an increase of dilution of the primary antibody. In the second run, HER2 over‐expression was found in 46 (40%) and 44 (38%) of the 116 cases, using 10% or 60% of stained cells as cut‐offs, respectively. The corresponding accuracy rates were 93% and 95%.Conclusions:  This study showed that a high accuracy of IHC could be obtained for the determination of HER2 status in all laboratories using their in‐house IHC technique, provided that a calibration process was performed. Antigen retrieval procedure, high dilutions of anti‐HER2 antibody and the use of specific controls were crucial for HER2‐IHC calibration. A 95% accuracy rate of IHC, using FISH as gold standard, was obtained by considering immunolabelling HER2‐IHC results as a continuous variable, and taking 60% invasive stained cells as the cut‐off for HER2 over‐expression.

Từ khóa


Tài liệu tham khảo

10.1038/modpathol.3880228

10.1200/JCO.1999.17.7.1983

10.1200/JCO.2001.19.2.354

10.1200/JCO.2000.18.21.3651

10.1200/JCO.1999.17.1.434

10.1200/JCO.1999.17.5.1644g

10.5858/2000-124-0966-PFIBC

10.1136/jcp.53.12.890

MassRD SandersC CharleneK.The concordance between the clinical trials assay (CTA) and fluorescence in situ hybridisation (FISH) in the Herceptin pivotal trials. InOncolPASCed.ASCO2000.

Kallioniemi O, 1992, ERBB2 amplification in breast cancer analysed by fluorescence in situ hybridization, Proc. Am. Soc. Clin. Oncol., 89, 5321

Persons DL, 1997, Quantitation of HER‐2/neu and c‐myc gene amplification in breast carcinoma using fluorescence in situ hybridization, Mod. Pathol., 10, 720

10.1093/jnci/85.15.1230

10.1038/bjc.1988.238

Masood S, 2000, Assessment of Her2/neu overexpression in primary breast cancers and their metastatic lesions: an immunohistochemical study, Ann. Clin. Lab. Sci., 30, 259

10.1002/cncr.10456

10.1002/path.1711730111

Haerslev T, 1993, Microwave processing of formalin‐fixed and paraffin embedded sections improves the immunoreactivity of c‐erbB‐2 oncoprotein in breast carcinoma, Appl. Immunohistochem., 1, 223

Press M, 1994, Sensitivity of HER‐2/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression, Cancer Res., 54, 2771

10.1309/AJ84-50AK-1X1B-1Q4C

Gown AM, 1993, Microwave‐based antigenic unmasking: a revolutionary new technique for routine immunohistochemistry, Appl. Immunohistochem., 1, 256

10.1126/science.2470152

10.1038/modpathol.3880154

10.1309/VACP-VLQA-G9DX-VUDF

10.1200/JCO.2001.19.10.2714

10.1200/JCO.1999.17.7.1974

10.1093/jnci/93.15.1120

10.1200/JCO.2000.18.18.3230

10.1023/A:1011120309910

Penault‐Llorca F, 1999, Quality challenge for immunohistochemistry: example of the ERBB‐2 status in breast cancer. Group for evaluation of prognostic factors in immunohistochemistry in breast cancer, Ann. Pathol., 19, 280

Thông tin
Thông tin xuất bản

Histopathology

Tập 42 Số 4

337-347

Thông tin tác giả